Fleury SA operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other
pharmaceutical manufacturers in Latin America:
Diagnosticos Da America SA
sales of 4.36 billion Brazilian Reals [US$866.50 million]
of which 100%
was servi os auxiliares),
(3.29 billion Brazilian Reals [US$654.11 million]
Genomma Lab Internacional Sab De Cv
based in MEXICO
(12.76 billion Mexican Pesos [US$532.69 million]
During the year ended December of 2019, sales at
Fleury SA were 2.91 billion Brazilian Reals (US$576.75 million).
increase of 9.0%
versus 2018, when the company's sales were 2.66 billion Brazilian Reals.
This was the fifth consecutive year of sales increases at Fleury SA
(and since 2014, sales have increased a total of 73%).
Sales of Diagnostic Medicine saw an increase
9.3% in 2019, from
2.23 billion Brazilian Reals to 2.44 billion Brazilian Reals.